These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19927283)

  • 1. A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin.
    Semeraro M; Thomée C; Rolland E; Le Deley MC; Rosselini D; Troalen F; Amoroso L; Dubrel M; Hartmann O
    Pediatr Blood Cancer; 2010 Feb; 54(2):284-90. PubMed ID: 19927283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
    Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
    Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
    Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
    Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
    Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
    Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin.
    Demirkaya M; Tugcu D; Akcay A; Aydogan G; Akıcı F; Salcioglu Z; Ekmekci H; Sevinir B; Balci Ekmekci O
    Pediatr Hematol Oncol; 2015; 32(7):482-9. PubMed ID: 26271020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?
    Robinson JO; Lamoth F; Bally F; Knaup M; Calandra T; Marchetti O
    PLoS One; 2011 Apr; 6(4):e18886. PubMed ID: 21541027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of procalcitonin in febrile neutropenic patients: review of the literature.
    Sakr Y; Sponholz C; Tuche F; Brunkhorst F; Reinhart K
    Infection; 2008 Oct; 36(5):396-407. PubMed ID: 18759057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
    Reitman AJ; Pisk RM; Gates JV; Ozeran JD
    Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?
    Schüttrumpf S; Binder L; Hagemann T; Berkovic D; Trümper L; Binder C
    Ann Hematol; 2003 Feb; 82(2):98-103. PubMed ID: 12601488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
    Lodahl D; Schrøder H
    Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.
    Engel A; Steinbach G; Kern P; Kern WV
    Scand J Infect Dis; 1999; 31(2):185-9. PubMed ID: 10447330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin-a new diagnostic tool in complications following liver transplantation.
    Kuse ER; Langefeld I; Jaeger K; Külpmann WR
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S187-92. PubMed ID: 18470718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of dual-phase 18F-FDG SPECT with serum procalcitonin for identification of etiology in tumor patients with fever of unknown origin.
    Zhang Q; Shan C; Wu P; Huang XE
    Asian Pac J Cancer Prev; 2014; 15(2):683-6. PubMed ID: 24568478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
    Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
    Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.